HSBC Upgrades US Stocks as Focus Shifts to Earnings From War

HSBC upgraded US equities to a buy-equivalent rating as geopolitical risks ease and earnings momentum turns decisively positive. HSBC cited expected profit growth of 14% in the three months through March, which would be the fastest expansion since 2024. The call is supportive for US stocks, though it is an analyst view rather than a direct corporate event.

Analysis

The market is likely underappreciating how quickly the earnings narrative can overpower macro/geopolitical noise once breadth in profit revisions turns positive. That usually helps the highest-beta, most earnings-sensitive parts of the US market first: cyclicals, semis, financials, and small/mid caps with operating leverage, while defensives become relative funding sources. If the expected profit acceleration is real, index-level upside can broaden even if leadership narrows, because multiple expansion becomes easier when forward estimates are being revised up rather than down.

The second-order effect is that easing war-risk premium can work like a hidden tightening reversal: lower energy/input-cost uncertainty, less forced cash hoarding, and better visibility on capex plans. That tends to compress volatility and lift cyclically exposed global suppliers, but it also reduces the premium paid for “safety” factors and commodity hedges. The biggest beneficiary may be companies where consensus was too cautious on margin recovery, not necessarily the highest nominal earners.

The key risk is that earnings momentum is often a lagging indicator right before it peaks. If the upside is being driven by easy comps or a temporary restocking cycle, the next 1-2 quarters could look strong while forward guidance disappoints, especially if rates stay restrictive or the dollar re-strengthens. A renewed geopolitical flare-up would matter most through oil and shipping costs rather than direct index-level beta, but that would likely hit the market fastest via margin-sensitive sectors.

Consensus may be too quick to treat this as a simple risk-on regime shift. The move feels potentially underdone in equal-weight and domestically oriented cyclicals, while mega-cap quality may already reflect much of the optimism. The cleaner expression is probably not broad index beta, but a rotation toward earnings-upgraded, valuation-discounted names with operating leverage and away from crowded defensive growth.

Key Decisions for Investors

• Go long XLI vs. XLP for the next 4-8 weeks: if earnings revisions stay positive, industrials should outperform staples as pricing power and volume leverage reassert; stop if crude and freight spikes reverse the margin thesis.
• Add to SMH on pullbacks over the next 1-2 months: semis are the highest convexity way to play a fundamentals-led rally, but size modestly because the trade breaks if forward guidance softens even with strong current quarter results.
• Pair long IWM / short SPLV for a 1-3 month window: small caps should benefit most from improved sentiment and lower war-risk premium, but only if rates do not re-tighten; this is a higher-beta expression of the earnings inflection.
• Buy 1-2 month call spreads on SPY or QQQ rather than outright calls: the market may already discount some of the good news, so defined-risk upside participation is better than chasing delta after a sentiment shift.
• Hedge with short energy exposure if geopolitical headlines fade further: XLE underperforms in a regime where war-risk premium comes out of commodities faster than it comes out of equities.